US Patent Issued to BASF on July 7 for "Method for preparing an enantiomerically enriched form of 2-[2-(2-chlorothiazol-5-yl)-2-hydroxy-ethylsulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one" (German, Indian, Swiss Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,943, issued on July 7, was assigned to BASF SE (Ludwigshafen, Germany).

"Method for preparing an enantiomerically enriched form of 2-[2-(2-chlorothiazol-5-yl)-2-hydroxy-ethylsulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one" was invented by Martin John Mclaughlin (Liestal, Switzerland), Christopher Koradin (Ludwigshafen, Germany), Rahul Kaduskar (Navi Mumbai, India), Harish Shinde (Navi Mumbai, India), Roland Goetz (Ludwigshafen, Germany) and Guillaume Michel Jacques Garivet (Ludwigshafen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for preparing 2-[2-(2-chlorothiazol-5-yl)-2-hydroxy-ethyl]sulfa...